HomeNVIVQ • OTCMKTS
add
Invivo Therapeutics Holdings Corp
Previous close
$0.37
Day range
$0.37 - $0.37
Year range
$0.15 - $0.39
Market cap
1.15M USD
Avg Volume
33.06K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
.INX
1.26%
1.00%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.83M | 1.00% |
Net income | -2.70M | 2.11% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.82M | -1.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.58M | -19.02% |
Total assets | 9.58M | -28.24% |
Total liabilities | 666.00K | -79.56% |
Total equity | 8.92M | — |
Shares outstanding | 3.11M | — |
Price to book | 0.13 | — |
Return on assets | -61.70% | — |
Return on capital | -66.54% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -2.70M | 2.11% |
Cash from operations | -2.28M | 3.71% |
Cash from investing | 43.00K | 170.49% |
Cash from financing | — | — |
Net change in cash | -2.24M | 7.90% |
Free cash flow | -1.05M | 47.52% |
About
Founded
2003
Website
Employees
6